Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
National Institutes of Health
Posted Sep 1, 2026
Description
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for an Infectious Diseases Clinical Trials Network (IDCTN). The IDCTN, comprised of the Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), supports the evaluation of interventions for emerging and chronic infections. The CTEUs design and implement clinical trials and studies, while the NCC provides the administrative and operational framework for a collaborative, integrated network and engages with experts in the field to solicit and generate clinical trial concepts. The NCC and CTEUs will collaboratively create opportunities to advance investigators early in their careers and those new to the field.
AI Summary
This funding opportunity supports the establishment of an Infectious Diseases Clinical Trials Network (IDCTN) to evaluate interventions for emerging and chronic infections through clinical trials. Eligible applicants include organizations that can form Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC) to collaborate on these trials.
Funding Details
Key Dates
Quick Facts
- CFDA Number
- 93.855
- Funder Type
- Federal Agency
- Grant Level
- FEDERAL
- Last Verified
- Sep 1, 2026
Categories
Geographic Scope
national
GL-1E17FE1e17fe2b-1a72-42bc-ac7b-796010f8160e
Intelligence
Ready to apply?
Visit the funder's website to start your application.